Foresite Capital Management IV as of Dec. 31, 2017
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 13 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed (INSM) | 19.2 | $27M | 880k | 31.18 | |
| Ascendis Pharma A S (ASND) | 14.9 | $21M | 529k | 40.06 | |
| Cymabay Therapeutics | 14.5 | $21M | 2.3M | 9.20 | |
| Immunomedics | 12.2 | $17M | 1.1M | 16.16 | |
| Myokardia | 9.1 | $13M | 309k | 42.10 | |
| Uniqure Nv (QURE) | 8.7 | $12M | 635k | 19.59 | |
| Optinose (OPTN) | 6.0 | $8.5M | 450k | 18.90 | |
| Aclaris Therapeutics (ACRS) | 4.3 | $6.2M | 252k | 24.66 | |
| Biohaven Pharmaceutical Holding | 4.0 | $5.8M | 213k | 26.98 | |
| Rhythm Pharmaceuticals (RYTM) | 3.6 | $5.1M | 175k | 29.06 | |
| Alder Biopharmaceuticals | 1.9 | $2.7M | 233k | 11.45 | |
| Denali Therapeutics (DNLI) | 1.0 | $1.5M | 95k | 15.64 | |
| Arbutus Biopharma (ABUS) | 0.5 | $761k | 151k | 5.05 |
